Sun Pharmaceutical Industries Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Sep-24 | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 |
|---|---|---|---|---|---|---|---|---|
| 13,291 | 13,675 | 12,959 | 13,851 | 14,478 | 15,521 | 14,612 | 15,300 | |
| 354 | 466 | 613 | 464 | 470 | 579 | 459 | 724 | |
| 10,048 | 10,349 | 9,956 | 10,325 | 10,781 | 11,383 | 11,519 | 11,721 | |
| 1,639 | 1,408 | 1,845 | 1,772 | 1,622 | 1,813 | 2,182 | 2,026 | |
| 875 | 1,239 | 1,037 | 1,048 | 1,088 | 922 | 753 | 1,020 | |
| 180 | 94 | −245 | −5 | 273 | 209 | −135 | −83 | |
| 2,478 | 2,552 | 2,489 | 2,802 | 2,765 | 2,892 | 2,960 | 3,227 | |
| 69 | 52 | 49 | 75 | 100 | 78 | 86 | 100 | |
| 626 | 631 | 664 | 701 | 730 | 732 | 775 | 739 | |
| 4,181 | 4,374 | 4,117 | 3,933 | 4,204 | 4,735 | 4,896 | 4,692 | |
| 4,293 | 4,158 | 3,967 | 3,948 | 4,997 | 5,038 | 4,413 | 4,937 | |
| 3,667 | 3,528 | 3,303 | 3,248 | 4,267 | 4,306 | 3,637 | 4,198 | |
| — | −316 | −362 | −818 | — | −489 | — | −204 | |
| 3,598 | 3,476 | 3,254 | 3,173 | 4,168 | 4,227 | 3,551 | 4,099 | |
| 567 | 559 | 1,094 | 870 | 1,031 | 826 | 828 | 1,188 | |
| 3,037 | 2,913 | 2,154 | 2,293 | 3,125 | 3,381 | 2,710 | 2,901 | |
| Financial ratios | ||||||||
| 32.30% | 30.41% | 30.61% | 28.50% | 34.51% | 32.46% | 30.20% | 32.27% | |
| 22.85% | 21.30% | 16.62% | 16.55% | 21.58% | 21.79% | 18.54% | 18.96% | |
| 12.70 | 12.10 | 9.00 | 9.50 | 13.00 | 14.00 | 11.30 | 12.10 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.